Crossref
Gemcitabine in pediatric refractory CNS GCT: a case of liver veno-occlusive disease
Clinical Oncology · 2026-09 · 57 · 104259
DOI: 10.1016/j.clon.2026.104259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology, 2026-09. Verfasst von G. Megaro und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Megaro, G., Baldo, G. D., Alessi, I., Miele, E., Ioris, M. D., D’Antonio, F., Cacchione, A., & Mastronuzzi, A. (2026). Gemcitabine in pediatric refractory CNS GCT: a case of liver veno-occlusive disease. Clinical Oncology, 57, 104259. https://doi.org/10.1016/j.clon.2026.104259
Vancouver
Megaro G, Baldo GD, Alessi I, Miele E, Ioris MD, D’Antonio F, et al. Gemcitabine in pediatric refractory CNS GCT: a case of liver veno-occlusive disease. Clinical Oncology. 2026;57:104259. doi:10.1016/j.clon.2026.104259
BibTeX
@article{Megaro2026,
author = {Megaro, G. and Baldo, G. Del and Alessi, I. and Miele, E. and Ioris, M.A. De and D’Antonio, F. and Cacchione, A. and Mastronuzzi, A.},
title = {Gemcitabine in pediatric refractory CNS GCT: a case of liver veno-occlusive disease},
journal = {Clinical Oncology},
year = {2026},
volume = {57},
pages = {104259},
doi = {10.1016/j.clon.2026.104259}
}
EUVIMED